Securities code: Tibet Duo Rui Pharmaceutical Co.Ltd(301075) securities abbreviation: Tibet Duo Rui Pharmaceutical Co.Ltd(301075) Announcement No.: 2022027 Tibet Duo Rui Pharmaceutical Co.Ltd(301075)
Indicative announcement of 2021 annual report and summary disclosure
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Tibet Duo Rui Pharmaceutical Co.Ltd(301075) (hereinafter referred to as “the company”) held the 11th meeting of the first board of directors and the 9th meeting of the first board of supervisors on March 23, 2022, and deliberated and adopted the annual report 2021 and its summary. In order to enable investors to fully understand the company’s operation and financial status, the company’s 2021 annual report and its summary were posted on the gem information disclosure website cninfo.com designated by the CSRC on March 25, 2022（ http://www.cn.info.com.cn. ）Disclosure.
Please pay attention to the investors.
It is hereby announced.
Tibet Duo Rui Pharmaceutical Co.Ltd(301075) board of directors March 24, 2022
